EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

PERFORMANCE OF CORD BLOOD ALBUMIN AT BIRTH FOR PREDICTION OF SIGNIFICANT NEONATAL HYPERBILIRUBINEMIA

*Dr. Zahoor Hussain Daraz, Dr. Berkheez Shabir and Dr. Rehana Afshan

ABSTRACT

TITLE “Performance of Cord Blood Albumin at Birth for Prediction of Significant Neonatal Hyperbilirubinemia”. Background: Neonatal Jaundice is one of the commonest problems that occur in a newborn and most of the times it is physiological. However, a few (5-6%) become deeply jaundiced requiring immediate intervention. The cause of this significant hyperbilirubinemia has been attributed to many factors including a low concentration of bilirubin binding ligand Albumin. Henceforth Albumin in a critical concentration is of considerable importance in development of hyperbilirubinemia. Moreover, American Academy of Pediatrics recommends that newborn discharged within 48 hours should have a follow-up visit after 72 hours for any significant jaundice. The present study was therefore conducted to find out the cut off value of cord blood albumin at birth that can predict significant Neonatal Hyperbilirubinemia. Objective: To evaluate the performance of cord blood albumin at birth for prediction of significant Neonatal Hyperbilirubinemia with respect to sensitivity and specificity through receiver operator curve (ROC). Method: This prospective observational study was performed on 70 healthy term neonates. Relevant maternal history was taken. Neonates with low birth weight, perinatal asphyxia or septicemia were excluded. Cord blood was collected at birth and Cord Serum Albumin level (CSA) was measured. Study subjects were divided into 2 groups based on Cord Serum Albumin level. Neonates were assessed clinically every day. Total Serum Bilirubin (TSB) was measured during 72-96 hours of life. Total Serum Bilirubin (TSB) value ≥17mg/dl is considered significant Neonatal Hyperbilirubinemia (NH) requiring intervention like phototherapy (PT) or Exchange transfusion (ExT). Breast feeding was ensured and dehydration was excluded in each neonate. Result: Study population was divided into 02 groups based on Cord Serum Albumin (CSA) level at birth. Cord Serum Albumin level varied between 2.4g/dl to 4.5 g/dl. Mean Cord Serum Albumin level in Group-I was 2.58±0.12 and of group-II was 3.30±0.30 g/dl respectively and the difference among the 2 groups was significant; however, there was no significant difference between mean gestational age and mean birth weight of the 02 groups. (39.15weeks ±1.28 vs 39.09weeks ±0.15; 2877.6grams ±184.5 vs. 2850.5grams ±215.4. There was significant negative correlation seen between Cord Serum Albumin and Neonatal Hyperbilirubinemia (NH). Receiver operator curve (ROC) analysis was done and a cutoff point of 2.7 g/dL was determined with a sensitivity of 81.81%, specificity 96.6% for prediction of significant Neonatal Hyperbilirubinemia. Conclusion: Cord blood Albumin concentration at birth is a good predictor for significant hyperbilirubinemia and Cord Blood Albumin level of ≤2.7 g/dL has sensitivity of 81.81% and specificity of 96.5% in predicting Significant Neonatal Hyperbilirubinemia.

Keywords: CSA, TSB.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here